AUA 2024: Predicting Response to Intravesical BCG in High Risk Non-Muscle Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12 Center Cohort
AUA 2024 non-invasive bladder cancer, artificial intelligence-powered pathology assay for predicting response to intravesical BCG, non-muscle invasive bladder cancer (NMIBC), CHAI assay.